FDA Import Refusal 8GQ-0058168-5/21/2J — GlaxoWellcome Production

GlaxoWellcome Production — FEI 3002807436

The FDA refused shipment 8GQ-0058168-5/21/2J from GlaxoWellcome Production (France) on Jun 24, 2024. The refused product falls under Drugs and Biologics — ALBENDAZOLE (ANTHELMINTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Jun 24, 2024
Country
France
Product Category
Drugs and Biologics
Product Code
60WCB01 ALBENDAZOLE (ANTHELMINTIC)
Charges
75